ChrysCapital, Capital Group sell 7.6% in Mankind for Rs 5,589 crore

New Delhi: ChrysCapital and Capital Group on Tuesday divested a total of 7.6% stake in pharmaceutical company Mankind Pharma for ₹5,589 crore through open market transactions. Following the stake sale, shares of Mankind Pharma declined 3.61% to settle at ₹1,849.45 on the BSE.

Beige Ltd, an affiliate of private equity firm ChrysCapital, pared 4.47% stake while Capital Group affiliates Cairnhill CIPEF and Hema CIPEF (I) offloaded a 3.14% stake in Mankind Pharma.

On the BSE, Kotak Funds India Midcap Fund acquired 2.0 million shares of at an average price of ₹1,832.30 apiece, taking the deal size to ₹372 crore.